The Vanderbilt findings provide «proof - of - concept that targeting an antitumor
agent to an intracellular protein may increase antitumor selectivity and improve the
therapeutic window for treating naturally
occurring cancers,» said first author Jashim Uddin, Ph.D., research associate professor of Biochemistry.